BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

26 related articles for article (PubMed ID: 8625169)

  • 1. Transcriptome profiling of cancer tissues in Chinese patients with gastric cancer by high-throughput sequencing.
    Tian P; Liang C
    Oncol Lett; 2018 Feb; 15(2):2057-2064. PubMed ID: 29434905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive value of tissue inhibitor of metalloproteinases-1 and carcinoembryonic antigen plasma levels in response to chemotherapy in patients with metastatic colorectal cancer.
    Roayaei M; Emami H; Adeli P; Rezaei A; Akbari M
    J Res Med Sci; 2014 Dec; 19(12):1129-33. PubMed ID: 25709652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrin alpha(v)beta6-associated ERK2 mediates MMP-9 secretion in colon cancer cells.
    Gu X; Niu J; Dorahy DJ; Scott R; Agrez MV
    Br J Cancer; 2002 Jul; 87(3):348-51. PubMed ID: 12177807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitation of TIMP-1 in plasma of healthy blood donors and patients with advanced cancer.
    Holten-Andersen MN; Murphy G; Nielsen HJ; Pedersen AN; Christensen IJ; Høyer-Hansen G; Brünner N; Stephens RW
    Br J Cancer; 1999 May; 80(3-4):495-503. PubMed ID: 10408859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of matrilysin (MMP-7) to the metastatic pathway of human colorectal cancers.
    Adachi Y; Yamamoto H; Itoh F; Hinoda Y; Okada Y; Imai K
    Gut; 1999 Aug; 45(2):252-8. PubMed ID: 10403738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Matrix metalloproteinases in gastrointestinal cancer.
    Brown PD
    Gut; 1998 Aug; 43(2):161-3. PubMed ID: 10189836
    [No Abstract]   [Full Text] [Related]  

  • 7. Measurement of matrix metalloproteinases and tissue inhibitors of metalloproteinases in blood and tissues. Clinical and experimental applications.
    Zucker S; Hymowitz M; Conner C; Zarrabi HM; Hurewitz AN; Matrisian L; Boyd D; Nicolson G; Montana S
    Ann N Y Acad Sci; 1999 Jun; 878():212-27. PubMed ID: 10415733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Matrix metalloproteinases and their inhibitors in ovarian cancer progression--diagnostic and therapeutic implications].
    Stettner R; Bogusiewicz M; Rechberger T
    Ginekol Pol; 2009 Jan; 80(1):47-53. PubMed ID: 19323060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Matrix metalloproteinases 1 and 3, tissue inhibitor of metalloproteinase-1 and the complex of metalloproteinase-1/tissue inhibitor in plasma of patients with prostate cancer.
    Jung K; Nowak L; Lein M; Priem F; Schnorr D; Loening SA
    Int J Cancer; 1997 Apr; 74(2):220-3. PubMed ID: 9133459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas.
    Nakano A; Tani E; Miyazaki K; Yamamoto Y; Furuyama J
    J Neurosurg; 1995 Aug; 83(2):298-307. PubMed ID: 7616276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of extracellular matrix-degrading proteinase and its inhibitor in gynecologic cancer tissues with clinically different metastatic form.
    Tamakoshi K; Kikkawa F; Nawa A; Ishikawa H; Mizuno K; Tamakoshi A; Yamagata S; Suganuma N; Tomoda Y
    Cancer; 1995 Dec; 76(12):2565-71. PubMed ID: 8625086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum metalloproteinases and their inhibitors: markers for malignant potential.
    Baker T; Tickle S; Wasan H; Docherty A; Isenberg D; Waxman J
    Br J Cancer; 1994 Sep; 70(3):506-12. PubMed ID: 8080738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matrix metalloproteinases as diagnostic (MMP-13) and prognostic (MMP-2, MMP-9) markers of prostate cancer.
    Morgia G; Falsaperla M; Malaponte G; Madonia M; Indelicato M; Travali S; Mazzarino MC
    Urol Res; 2005 Feb; 33(1):44-50. PubMed ID: 15517230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma assay of gelatinase B: tissue inhibitor of metalloproteinase complexes in cancer.
    Zucker S; Lysik RM; DiMassimo BI; Zarrabi HM; Moll UM; Grimson R; Tickle SP; Docherty AJ
    Cancer; 1995 Aug; 76(4):700-8. PubMed ID: 8625169
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.